Anti-TNF Therapy Is Emerging as the Primary Treatment Modality in Pediatric Inflammatory Bowel Disease

被引：4
|
作者：
Niklinska-Schirtz, B. Joanna [1 ]
Kugathasan, Subra [1 ]
机构：
[1] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
来源：
INFLAMMATORY BOWEL DISEASES | 2020年 / 26卷 / 01期
关键词：
CROHNS-DISEASE; CHILDREN; 6-MERCAPTOPURINE; METHOTREXATE; EXPERIENCE; TERM;
D O I：
10.1093/ibd/izz158
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
A population-based Canadian study found an increasing trend in utilization of anti-tumor necrosis factor agents in pediatric inflammatory bowel disease (IBD), also reporting that immunomodulator use is on the decline. This accompanying editorial discusses this emerging trend occurring in pediatric IBD world-wide. Data from the Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn's Disease (RISK) study are presented and confirm the same trend among pediatric IBD in the United States.
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [41] Anti-TNF Treatment in Inflammatory Bowel Disease Patients Diagnosed in Adolescence
    Naik, Amar S.
    Asamoah, Nikiya
    Zadvornova, Yelena
    Perera, Lilani P.
    Stein, Daniel J.
    Saeian, Kia
    Venu, Nanda
    GASTROENTEROLOGY, 2012, 142 (05) : S362 - S362
  • [42] Anti-TNFα/azathioprine therapy modulates the Natural killer cell compartment in pediatric inflammatory bowel disease
    Knieling, F.
    Schnell, A.
    Allabauer, I.
    Schwarz, B.
    Rechenauer, T.
    Kaspar, S.
    Siebenlist, G.
    Rueckel, A.
    Hartmann, A.
    Wahlbuhl-Becker, M.
    Hoerning, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 147 - 148
  • [43] Inflammatory bowel disease: anti-TNF strategies and beyond
    Hoffmann, JC
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 : S76 - S78
  • [44] Inflammatory bowel disease after anti-TNF drugs
    Hamilton, Louise
    Griffin, Jane
    Dahiya, Sandeep
    Somerville, Margaret
    Stodell, Malcolm
    RHEUMATOLOGY, 2008, 47 : II18 - II18
  • [45] Optimizing anti-TNF treatments in inflammatory bowel disease
    Ben-Horin, Shomron
    Kopylov, Uri
    Chowers, Yehuda
    AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 24 - 30
  • [46] The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease
    Paschou, Stavroula A.
    Palioura, Eleni
    Kothonas, Fotios
    Myroforidis, Alexandros
    Loi, Vasiliki
    Poulou, Androniki
    Goumas, Konstantinos
    Effraimidis, Grigoris
    Vryonidou, Andromachi
    ENDOCRINE JOURNAL, 2018, 65 (11) : 1121 - 1125
  • [47] Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease
    Andrisani, G.
    Guidi, L.
    Papa, A.
    Armuzzi, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (07) : 890 - 901
  • [48] Increased Risk of Preeclampsia in Women With Inflammatory Bowel Disease on Anti-TNF Therapy
    Kattah, Andrea
    Becker, Brenda
    Kane, Sunanda
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S444 - S444
  • [49] Serious infective complications associated with anti-TNFα therapy in inflammatory Bowel disease
    Lawrance, I. C.
    Bampton, P. A.
    Sparrow, M.
    Gearry, R. B.
    Leong, R. W.
    Andrews, J. M.
    Florin, T. H. J.
    Croft, A.
    Radford-Smith, G. L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A195 - A195
  • [50] Efficacy and Safety of Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease
    Ortega, Triana Lobaton
    Vermeire, Severine
    Ballet, Vera
    Rutgeerts, Paul J.
    Van Assche, Gert A.
    Ferrante, Marc
    GASTROENTEROLOGY, 2014, 146 (05) : S579 - S579
12345